Condition
Post Prandial Distress Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
P 2 (1)
P 4 (3)
Trial Status
Terminated1
Not Yet Recruiting1
Completed1
Withdrawn1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07449689Phase 4Not Yet Recruiting
Comparing Acotiamide and Itopride for the Management of Indigestion
NCT00673972Phase 4Withdrawn
Comparative Study of Epigastric Pain Syndrome and Postprandial Distress Syndrome
NCT00663897Phase 4Completed
Lansoprazole Versus Mosapride for Functional Dyspepsia
NCT00630370Phase 2TerminatedPrimary
A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome
Showing all 4 trials